The roll-up lens — proving the thesis deal by deal, and surfacing the integration drag that holds margin back.
The roll-up thesis is working — +$519.7499999999999M of EBITDA captured and 74% of synergy banked — but 4 in-flight businesses ($3573.25M revenue) still hold margin back. Finish their cutover to close the gap to 100% synergy, the highest-return work in the company.
4 of 4 headline metrics improving vs prior · still off target: Synergy Realized 4.5% vs 6.0%, Days Sales Outstanding 62d vs 60d, Recurring Revenue Mix 8.2% vs 10.0%
Avg synergy is only 74% of plan banked; the unrealized balance is EBITDA already underwritten but not yet captured.
Syngenta Flowers is the weakest cohort on synergy capture; a 90-day savings plan on the gap is unrealized EBITDA.
Move to credit hold pending paydown; reforecast ARR net of likely churn.
Distress filings + overdue AR; churn risk High on $6.4M account.
Gates the cohort cutover (and the exit).
Pavion is built by acquisition. This view shows, for each business bought, what we paid for vs what it earns now — and flags the ones still mid-integration where ~+$21M of profit, faster cash and lower churn are still on the table.
Finishing the 4 in-flight businesses (Syngenta Group China, Lawn & Garden, Cropwise, Syngenta Flowers) closes the gap to 100% — the single highest-return work in the company.
Each card: what changed since purchase, how far integration has gone, and the next move.
Each cohort ranked within the set on five KPIs (direction per metric), then a composite Overall Rank from summed rank points — the dashboard's RANKX leaderboard. Top & bottom highlighted.
| Overall | Unit | Revenue↑ better | EBITDA %↑ better | ARR↑ better | Synergy %↑ better | DSO gain↑ better | Rank pts |
|---|---|---|---|---|---|---|---|
| 1 | Syngenta Crop Protection | $2079M#1 | 347%#1 | $1126M#1 | 88%#3 | 12d#2 | 8 |
| 2 | Syngenta Seeds | $736M#5 | 303%#2 | $260M#5 | 92%#1 | 13d#1 | 14 |
| 3 | Syngenta Group China | $1256M#2 | 282%#3 | $411M#2 | 74%#5 | 9d#5 | 17 |
| 4 | Adama | $476M#7 | 282%#3 | $173M#7 | 90%#2 | 12d#2 | 21 |
| 4 | Cropwise | $801M#4 | 260%#5 | $282M#4 | 78%#4 | 11d#4 | 21 |
| 6 | Lawn & Garden | $888M#3 | 238%#6 | $303M#3 | 55%#6 | 6d#6 | 24 |
| 7 | Syngenta Flowers | $628M#6 | 195%#7 | $195M#6 | 40%#7 | 3d#7 | 33 |
Higher EBITDA %, revenue, ARR and synergy rank better; DSO gain = days of receivables improvement since acquisition (more = better). Composite rank points are the sum of the five per-KPI ranks (lower = better).
As-acquired → current across EBITDA, DSO, integration and synergy.
| Brand | Yr | Revenue | ARR | EBITDA % | DSO | Integrated | Synergy | Status |
|---|---|---|---|---|---|---|---|---|
| Syngenta Seeds | 2021 | $736.31M | $259.87M | 194.9→303.18 | 71→58d | 100% | 92% | Integrated |
| Adama | 2021 | $476.43M | $173.25M | 173.25→281.53 | 66→54d | 100% | 90% | Integrated |
| Syngenta Crop Protection | 2022 | $2078.98M | $1126.11M | 238.22→346.5 | 68→56d | 95% | 88% | Integrated |
| Syngenta Group China | 2023 | $1256.05M | $411.46M | 216.56→281.53 | 70→61d | 82% | 74% | In progress |
| Lawn & Garden | 2024 | $887.9M | $303.18M | 194.9→238.22 | 73→67d | 60% | 55% | In progress |
| Cropwise | 2024 | $801.27M | $281.53M | 194.9→259.87 | 71→60d | 80% | 78% | In progress |
| Syngenta Flowers | 2024 | $628.03M | $194.9M | 173.25→194.9 | 69→66d | 45% | 40% | Early |